FAP-Targeted Radiopharmaceutical Therapy using 177Lu-, 90Y- and 225Ac-labeled 3BP-3940 in a Cohort of 88 Patients with 21 Different Advanced Malignancies

Authors
Category Primary study
Conference2025 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, SNMMI 2025
Year 2025
This article has no abstract
Epistemonikos ID: 45a4e6d8c7a0a18b6996490982579bf8b9c34304
First added on: Sep 26, 2025